查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1797989

2032 年精神健康設備和平台新興市場預測：按產品類型、治療方法、年齡層、技術、應用、最終用戶和地區進行的全球分析

Emerging Mental Health Devices and Platforms Market Forecasts to 2032 - Global Analysis By Product Type (Platforms and Devices), Therapy, Age Group, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球新興心理健康設備和平台市場預計在 2025 年達到 51 億美元，到 2032 年將達到 174 億美元，預測期內的複合年成長率為 19.3%。

新興心理健康設備和平台是指旨在診斷、監測和管理心理健康狀況的先進數位工具和技術。這些設備包括穿戴式生物感測器、神經刺激設備、人工智慧聊天機器人、行動應用程式和虛擬治療平台。它們能夠即時追蹤心理狀態，提供遠端諮詢和個人化治療建議。在心理健康意識不斷增強和遠端醫療廣泛應用的推動下，這些創新正在徹底改變心理健康服務的提供方式，提高服務的可及性，減少污名化，並促進不同人群的積極情緒健康。

根據美國國家精神疾病聯盟 (2023) 的數據，美國五分之一的成年人會患有精神疾病，因此開發能夠提供即時支援和監控的人工智慧工具至關重要。

遠端醫療服務的採用率不斷提高

遠端醫療服務的快速普及是新興心理健康設備和平台市場的主要驅動力。對便捷便捷的心理健康支援服務的需求日益成長，推動了數位諮詢和基於應用程式的治療的廣泛應用。遠端醫療消除了地域障礙，減少了污名化，並實現了患者與治療師之間的即時互動。支持性發展、保險覆蓋範圍的擴大以及患者對虛擬護理日益成長的偏好，進一步加速了已開發地區和新興地區的市場發展，為數位心理健康創新提供了持續的動力。

設備開發安裝成本高

開發和部署心理健康設備的高成本是市場成長的主要限制因素。設計經臨床檢驗且易於使用的硬體，例如神經刺激設備和穿戴式生物感測器，需要大量的研發投入和合規性。新興企業和小型企業往往面臨資金和生產擴充性的困境。此外，與遠端醫療平台整合並確保資料安全通訊協定也增加了開發的複雜性，從而減緩了市場滲透，尤其是在資源匱乏的地區和服務不足的醫療機構中。

遠距心理健康監測需求不斷成長

遠距心理健康監測需求的不斷成長代表著該市場的巨大機會。能夠即時追蹤情緒、睡眠、心率變異性和壓力水平的穿戴式裝置和行動應用程式正日益受到患者和臨床醫生的青睞。這些工具能夠提供早期療育、個人化照護以及臨床以外的持續支持。隨著心理健康意識的不斷增強以及科技應用的日益普及，尤其是在年輕人群體中，遠端監測解決方案有望成為主動心理健康護理的核心組成部分。

數位治療的監管障礙

嚴格的數位療法法律規範對新興的精神健康設備和平台市場構成了重大威脅。要獲得FDA和EMA等機構的核准，需要進行嚴格的臨床試驗、資料隱私保護，並遵守不斷發展的遠端醫療法規。這些挑戰會延遲產品上市，並增加上市成本。此外，報銷政策和數位療法分類的不確定性也為開發者帶來了不確定性，扼殺了創新，並限制了經臨床驗證的數位精神健康解決方案的可用性。

COVID-19的影響：

由於心理困擾加劇，且獲得面對面護理的機會有限，COVID-19 疫情大大加速了數位心理健康解決方案的使用。封鎖和隔離措施推動了對虛擬治療平台、心理健康應用程式和遠端監控工具的需求。這場危機檢驗療法的擴充性，並增加了對心理健康新興企業的資金投入。隨著混合護理模式的日益普及，心理健康護理格局發生了重塑，數位平台作為長期心理健康策略的重要組成部分的地位也得到鞏固。

預計平台部分將成為預測期內最大的部分

受應用程式為基礎的療法、虛擬諮詢和心理健康計畫的普及推動，平台細分市場預計將在預測期內佔據最大市場佔有率。這些平台為患者和醫療保健提供者提供便利、可客製化、經濟高效且擴充性的解決方案。引導式冥想、主導聊天機器人和視訊治療課程等功能使平台成為各年齡層的首選。隨著數位心理健康生態系統的成熟，基於平台的解決方案在用戶採用率和市場佔有率方面將繼續超越以設備為中心的模式。

預計認知行為療法 (CBT) 領域在預測期內將以最高的複合年成長率成長。

認知行為療法 (CBT) 領域預計將在預測期內實現最高成長率，這得益於其在治療焦慮、憂鬱症和壓力相關疾病方面已證實的臨床有效性。透過應用程式和線上平台以數位化方式交付的 CBT 模組提供了一種便捷、結構化且經濟高效的治療方案。人工智慧驅動的 CBT 聊天機器人和自導式程式的興起正在使治療更加民主化，尤其對於偏遠和服務欠缺地區的患者。隨著心理健康素養的提高，對 CBT主導解決方案的需求將持續成長。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於心理健康意識的不斷增強、快速的都市化以及智慧型手機的高普及率。中國、印度和日本等國的政府和私人企業正在投資遠端醫療基礎設施和數位健康平台。文化上對精神疾病的非人性化以及職場心理健康舉措的增多，進一步促進了相關技術的採用。該地區不斷成長的年輕人口和不斷擴展的數位生態系統，正在推動心理健康應用程式和虛擬治療工具的快速普及。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率，這得益於先進的醫療基礎設施、高度的心理健康意識以及對數位療法的支持性法律規範。主要企業的湧現和強大的新興企業生態系統將推動創新。優惠的報銷政策、政府對遠距心理健康的資助以及雇主和保險公司日益普及的採用，都推動了該地區的快速成長。此外，疫情過後人們對心理健康的擔憂日益加劇，將繼續推動該地區對數位心理健康解決方案的需求。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球新興心理健康設備和平台市場（按產品類型）

  • 平台
  • 裝置

6. 全球新興心理健康設備與平台市場（依治療方法）

  • 認知行為治療（CBT）
  • 電療
  • 其他治療方法

7. 全球新興心理健康設備與平台市場（依年齡層）

  • 兒童和青少年
  • 成人
  • 老年人

8. 全球新興心理健康設備和平台市場（按技術）

  • 穿戴式科技
  • 行動應用程式
  • 平台和遠端醫療

9. 全球新興心理健康設備與平台市場（按應用）

  • 自我保健和健康
  • 治療
  • 心理健康評估與診斷
    • 壓力
    • 焦慮
    • 憂鬱症
    • 躁鬱症
  • 其他用途

10. 全球新興心理健康設備和平台市場（按最終用戶）

  • 病人
  • 醫療機構（醫院、診所）
  • 雇主
  • 其他最終用戶

11. 全球新興心理健康設備和平台市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章：公司概況

  • Acadia Healthcare
  • AbleTo Inc.
  • Amelia Virtual Care
  • CareTech Holding PLC
  • Clarigent Health
  • Compass Pathways
  • Electromedical Products International（EPI）
  • Eli Lilly and Co.
  • Feel Therapeutics
  • Flow Neuroscience
  • Headspace Inc.
  • Pear Therapeutics
  • Quartet Health
  • Spring Health
  • Talkspace Inc.
  • Teladoc Health Inc.
  • Woebot Health
Product Code: SMRC30359

According to Stratistics MRC, the Global Emerging Mental Health Devices and Platforms Market is accounted for $5.1 billion in 2025 and is expected to reach $17.4 billion by 2032 growing at a CAGR of 19.3% during the forecast period. Emerging mental health devices and platforms refer to advanced digital tools and technologies aimed at diagnosing, monitoring, and managing mental health conditions. These include wearable biosensors, neurostimulation devices, AI-powered chatbots, mobile apps, and virtual therapy platforms. They enable real-time mental state tracking, remote consultations, and personalized treatment recommendations. Spurred by increased mental health awareness and telehealth adoption, these innovations are revolutionizing mental healthcare delivery, improving accessibility, reducing stigma, and promoting proactive emotional well-being across diverse populations.

According to the National Alliance on Mental Illness (2023), with 1 in 5 U.S. adults experiencing mental illness, there is a growing emphasis on developing AI-powered tools that can provide real-time support and monitoring.

Market Dynamics:

Driver:

Increasing adoption of telehealth services

The rapid adoption of telehealth services is significantly driving the emerging mental health devices and platforms market. With growing demand for accessible and convenient mental health support, digital consultations and app-based therapies are gaining widespread traction. Telehealth breaks geographical barriers, reduces stigma, and enables real-time patient-therapist interaction. Government support, insurance coverage expansions, and evolving patient preferences toward virtual care are further accelerating market adoption across both developed and developing regions, creating sustained momentum for digital mental health innovation.

Restraint:

High device development and deployment costs

High costs associated with developing and deploying mental health devices pose a major restraint to market growth. Designing clinically validated, user-friendly hardware-such as neurostimulators and wearable biosensors-requires substantial R&D investment and regulatory compliance. Startups and small companies often struggle with limited funding and production scalability. Additionally, ensuring integration with telehealth platforms and data security protocols further adds to development complexity, slowing market penetration, particularly in resource-constrained environments or among underserved healthcare providers.

Opportunity:

Growing demand for remote mental health monitoring

The growing demand for remote mental health monitoring represents a major opportunity in the market. Wearables and mobile applications capable of tracking mood, sleep, heart rate variability, and stress levels in real-time are gaining popularity among patients and clinicians. These tools allow early intervention, personalized care, and continuous support beyond clinical settings. As awareness of mental well-being increases and technology adoption rises, especially among younger populations, remote monitoring solutions are poised to become central to proactive mental healthcare.

Threat:

Regulatory hurdles for digital therapeutics

Strict regulatory frameworks for digital therapeutics present a critical threat to the emerging mental health devices and platforms market. Gaining approval from agencies such as the FDA or EMA requires rigorous clinical trials, data privacy safeguards, and compliance with evolving telehealth laws. These challenges delay product launches and increase go-to-market costs. Moreover, uncertainty in reimbursement policies and classification of digital therapies creates ambiguity for developers, discouraging innovation and limiting the availability of clinically proven digital mental health solutions.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated the use of digital mental health solutions due to rising psychological distress and limited in-person care access. Lockdowns and isolation drove demand for virtual therapy platforms, mental health apps, and remote monitoring tools. The crisis validated the scalability of digital therapeutics and increased funding toward mental health tech startups. As hybrid care models become the norm, COVID-19 has reshaped the mental healthcare landscape, solidifying digital platforms as essential components of long-term mental health strategies.

The platforms segment is expected to be the largest during the forecast period

The platforms segment is expected to account for the largest market share during the forecast period, owing to widespread adoption of app-based therapies, virtual consultations, and mental wellness programs. These platforms offer scalable solutions that are accessible, customizable, and cost-effective for both patients and providers. Features like guided meditation, AI-driven chatbots, and video therapy sessions make platforms a preferred choice across age groups. As the digital mental health ecosystem matures, platform-based solutions continue to outpace device-centric models in user adoption and market presence.

The cognitive behavioral therapy (CBT) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive behavioral therapy (CBT) segment is predicted to witness the highest growth rate, impelled by its proven clinical efficacy in treating anxiety, depression, and stress-related disorders. Digitally delivered CBT modules via apps and online platforms offer accessible, structured, and cost-effective treatment options. The rise of AI-powered CBT chatbots and self-guided programs has democratized access, particularly for patients in remote or underserved areas. As mental health literacy increases, demand for CBT-driven solutions continues to accelerate.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rising mental health awareness, rapid urbanization, and strong smartphone penetration. Governments and private players across countries like China, India, and Japan are investing in telehealth infrastructure and digital wellness platforms. Cultural destigmatization of mental illness and increasing workplace mental health initiatives further contribute to adoption. The growing youth population and expanding digital ecosystems in the region are fostering rapid uptake of mental health apps and virtual therapy tools.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, attributed to advanced healthcare infrastructure, high mental health awareness, and supportive regulatory frameworks for digital therapeutics. The presence of leading mental health tech companies and a strong startup ecosystem accelerates innovation. Favorable reimbursement policies, government funding for tele-mental health, and increasing adoption by employers and insurers are contributing to rapid growth. Additionally, growing concerns around post-pandemic mental well-being continue to drive demand for digital mental health solutions in the region.

Key players in the market

Some of the key players in Emerging Mental Health Devices and Platforms Market include Acadia Healthcare, AbleTo Inc., Amelia Virtual Care, CareTech Holding PLC, Clarigent Health, Compass Pathways, Electromedical Products International (EPI), Eli Lilly and Co., Feel Therapeutics, Flow Neuroscience, Headspace Inc., Pear Therapeutics, Quartet Health, Spring Health, Talkspace Inc., Teladoc Health Inc. and Woebot Health.

Key Developments:

In June 2025, Acadia Healthcare expanded its digital mental health offerings in June 2025 by integrating new AI-powered therapy platforms for anxiety and depression management. These tools provide scalable remote patient engagement and real-time monitoring. Acadia also partnered with health insurers in the U.S. to improve reimbursement pathways.

In May 2025, AbleTo introduced expanded virtual care programs in May 2025 targeting chronic disease patients with co-morbid mental health conditions. The platform integrates evidence-based cognitive behavioral therapy (CBT) with personalized coaching, improving outcomes and reducing hospital readmissions.

In April 2025, Amelia Virtual Care launched an AI-driven chatbot in April 2025 to deliver 24/7 cognitive behavioral support and crisis intervention. The virtual assistant guides users through coping strategies and facilitates clinician escalation when needed.

Product Types Covered:

  • Platforms
  • Devices

Therapies Covered:

  • Cognitive Behavioral Therapy (CBT)
  • Electrotherapy
  • Other Therapies

Age Groups Covered:

  • Children/Adolescents
  • Adults
  • Seniors/Geriatric

Technologies Covered:

  • Wearable Tech
  • Mobile Apps
  • Platforms & Telemedicine

Applications Covered:

  • Self Management & Wellbeing
  • Treatment
  • Mental Health Assessment & Diagnosis
  • Other Applications

End Users Covered:

  • Patients
  • Providers (Hospitals, Clinics)
  • Employers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Emerging Mental Health Devices and Platforms Market, By Product Type

  • 5.1 Introduction
  • 5.2 Platforms
  • 5.3 Devices

6 Global Emerging Mental Health Devices and Platforms Market, By Therapy

  • 6.1 Introduction
  • 6.2 Cognitive Behavioral Therapy (CBT)
  • 6.3 Electrotherapy
  • 6.4 Other Therapies

7 Global Emerging Mental Health Devices and Platforms Market, By Age Group

  • 7.1 Introduction
  • 7.2 Children/Adolescents
  • 7.3 Adults
  • 7.4 Seniors/Geriatric

8 Global Emerging Mental Health Devices and Platforms Market, By Technology

  • 8.1 Introduction
  • 8.2 Wearable Tech
  • 8.3 Mobile Apps
  • 8.4 Platforms & Telemedicine

9 Global Emerging Mental Health Devices and Platforms Market, By Application

  • 9.1 Introduction
  • 9.2 Self Management & Wellbeing
  • 9.3 Treatment
  • 9.4 Mental Health Assessment & Diagnosis
    • 9.4.1 Stress
    • 9.4.2 Anxiety
    • 9.4.3 Depression
    • 9.4.4 Bipolar Disorder
  • 9.5 Other Applications

10 Global Emerging Mental Health Devices and Platforms Market, By End User

  • 10.1 Introduction
  • 10.2 Patients
  • 10.3 Providers (Hospitals, Clinics)
  • 10.4 Employers
  • 10.5 Other End Users

11 Global Emerging Mental Health Devices and Platforms Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Acadia Healthcare
  • 13.2 AbleTo Inc.
  • 13.3 Amelia Virtual Care
  • 13.4 CareTech Holding PLC
  • 13.5 Clarigent Health
  • 13.6 Compass Pathways
  • 13.7 Electromedical Products International (EPI)
  • 13.8 Eli Lilly and Co.
  • 13.9 Feel Therapeutics
  • 13.10 Flow Neuroscience
  • 13.11 Headspace Inc.
  • 13.12 Pear Therapeutics
  • 13.13 Quartet Health
  • 13.14 Spring Health
  • 13.15 Talkspace Inc.
  • 13.16 Teladoc Health Inc.
  • 13.17 Woebot Health

List of Tables

  • Table 1 Global Emerging Mental Health Devices and Platforms Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Emerging Mental Health Devices and Platforms Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Emerging Mental Health Devices and Platforms Market Outlook, By Platforms (2024-2032) ($MN)
  • Table 4 Global Emerging Mental Health Devices and Platforms Market Outlook, By Devices (2024-2032) ($MN)
  • Table 5 Global Emerging Mental Health Devices and Platforms Market Outlook, By Therapy (2024-2032) ($MN)
  • Table 6 Global Emerging Mental Health Devices and Platforms Market Outlook, By Cognitive Behavioral Therapy (CBT) (2024-2032) ($MN)
  • Table 7 Global Emerging Mental Health Devices and Platforms Market Outlook, By Electrotherapy (2024-2032) ($MN)
  • Table 8 Global Emerging Mental Health Devices and Platforms Market Outlook, By Other Therapies (2024-2032) ($MN)
  • Table 9 Global Emerging Mental Health Devices and Platforms Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 10 Global Emerging Mental Health Devices and Platforms Market Outlook, By Children/Adolescents (2024-2032) ($MN)
  • Table 11 Global Emerging Mental Health Devices and Platforms Market Outlook, By Adults (2024-2032) ($MN)
  • Table 12 Global Emerging Mental Health Devices and Platforms Market Outlook, By Seniors/Geriatric (2024-2032) ($MN)
  • Table 13 Global Emerging Mental Health Devices and Platforms Market Outlook, By Technology (2024-2032) ($MN)
  • Table 14 Global Emerging Mental Health Devices and Platforms Market Outlook, By Wearable Tech (2024-2032) ($MN)
  • Table 15 Global Emerging Mental Health Devices and Platforms Market Outlook, By Mobile Apps (2024-2032) ($MN)
  • Table 16 Global Emerging Mental Health Devices and Platforms Market Outlook, By Platforms & Telemedicine (2024-2032) ($MN)
  • Table 17 Global Emerging Mental Health Devices and Platforms Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Emerging Mental Health Devices and Platforms Market Outlook, By Self Management & Wellbeing (2024-2032) ($MN)
  • Table 19 Global Emerging Mental Health Devices and Platforms Market Outlook, By Treatment (2024-2032) ($MN)
  • Table 20 Global Emerging Mental Health Devices and Platforms Market Outlook, By Mental Health Assessment & Diagnosis (2024-2032) ($MN)
  • Table 21 Global Emerging Mental Health Devices and Platforms Market Outlook, By Stress (2024-2032) ($MN)
  • Table 22 Global Emerging Mental Health Devices and Platforms Market Outlook, By Anxiety (2024-2032) ($MN)
  • Table 23 Global Emerging Mental Health Devices and Platforms Market Outlook, By Depression (2024-2032) ($MN)
  • Table 24 Global Emerging Mental Health Devices and Platforms Market Outlook, By Bipolar Disorder (2024-2032) ($MN)
  • Table 25 Global Emerging Mental Health Devices and Platforms Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Emerging Mental Health Devices and Platforms Market Outlook, By End Users (2024-2032) ($MN)
  • Table 27 Global Emerging Mental Health Devices and Platforms Market Outlook, By Patients (2024-2032) ($MN)
  • Table 28 Global Emerging Mental Health Devices and Platforms Market Outlook, By Providers (Hospitals, Clinics) (2024-2032) ($MN)
  • Table 29 Global Emerging Mental Health Devices and Platforms Market Outlook, By Employers (2024-2032) ($MN)
  • Table 30 Global Emerging Mental Health Devices and Platforms Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.